Noveltreat is a generic formulation of Wygovy containing semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. It aids in weight management by reducing appetite and increasing insulin secretion, contributing to improved glycemic control and sustained weight loss in adults with obesity or overweight conditions.